On the occasion of Childhood Cancer Awareness Month, pediatric oncologist Paul A. Meyers talks about the evolution of pediatric cancer research and treatment at Memorial Sloan-Kettering.
In this “Ask the Expert” feature, pediatric hematologist Andromachi Scaradavou discusses options for expectant parents who are considering banking a newborn’s cord blood.
Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).
